SwePub
Sök i LIBRIS databas

  Extended search

L773:1570 9639 OR L773:1878 1454
 

Search: L773:1570 9639 OR L773:1878 1454 > Protein biomarker v...

Protein biomarker validation via proximity ligation assays

Blokzijl, Andries (author)
Uppsala universitet,Molekylära verktyg
Nong, Rachel (author)
Uppsala universitet,Molekylära verktyg
Darmanis, S. (author)
Uppsala universitet,Institutionen för immunologi, genetik och patologi
show more...
Hertz, E. (author)
Uppsala universitet,Institutionen för immunologi, genetik och patologi
Landegren, Ulf (author)
Uppsala universitet,Molekylära verktyg
Kamali-Moghaddam, Masood (author)
Uppsala universitet,Molekylära verktyg
show less...
 (creator_code:org_t)
Elsevier BV, 2014
2014
English.
In: Biochimica et Biophysica Acta - Proteins and Proteomics. - : Elsevier BV. - 1570-9639 .- 1878-1454. ; 1844:5, s. 933-939
  • Research review (peer-reviewed)
Abstract Subject headings
Close  
  • The ability to detect minute amounts of specific proteins or protein modifications in blood as biomarkers for a plethora of human pathological conditions holds great promise for future medicine. Despite a large number of plausible candidate protein biomarkers published annually, the translation to clinical use is impeded by factors such as the required size of the initial studies, and limitations of the technologies used. The proximity ligation assay (PLA) is a versatile molecular tool that has the potential to address some obstacles, both in validation of biomarkers previously discovered using other techniques, and for future routine clinical diagnostic needs. The enhanced specificity of PIA extends the opportunities for large-scale, high-performance analyses of proteins. Besides advantages in the form of minimal sample consumption and an extended dynamic range, the PLA technique allows flexible assay reconfiguration. The technology can be adapted for detecting protein complexes, proximity between proteins in extracellular vesicles or in circulating tumor cells, and to address multiple post-translational modifications in the same protein molecule. We discuss herein requirements for biomarker validation, and how PLA may play an increasing role in this regard. We describe some recent developments of the technology, including proximity extension assays, the use of recombinant affinity reagents suitable for use in proximity assays, and the potential for single cell proteomics. This article is part of a Special Issue entitled: Biomarkers: A Proteomic Challenge. (C) 2013 Elsevier B.V. All rights reserved.

Subject headings

NATURVETENSKAP  -- Biologi -- Biokemi och molekylärbiologi (hsv//swe)
NATURAL SCIENCES  -- Biological Sciences -- Biochemistry and Molecular Biology (hsv//eng)
NATURVETENSKAP  -- Biologi -- Biofysik (hsv//swe)
NATURAL SCIENCES  -- Biological Sciences -- Biophysics (hsv//eng)

Keyword

Biomarkers
Protein detection
Proximity ligation assay
Diagnostic

Publication and Content Type

ref (subject category)
for (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view